NEPHRO CARE SHARES
Does NSE's price capping on SME IPOs mean no multibagger returns on Day 1?
As SME IPOs gain traction among investors, regulators are moving to formalise the market with stricter controls. The NSE recently imposed a cap on SME issue listing prices at 90%, independent of grey market trends. This impacted Nephro Care, which despite a 300% pre-listing GMP, debuted at only a 90% premium due to the exchange's price cap.
Nephro Care shares list at 90% premium on NSE SME platform
Nephro Care made a strong market debut on NSE SME platform with a 90% premium. The IPO garnered massive investor interest, oversubscribed by over 700 times. The company aims to establish a 100-bed multispeciality hospital in Kolkata using proceeds from the IPO. Nephro Care, led by Dr. Pratim Sengupta, focuses on comprehensive medical services for renal patients.
Ambey Laboratories opens today: Check issue size, price band, GMP & other details
Ambey Laboratories’ SME IPO, aiming to raise Rs 44.68 crore by July 8, offers shares at Rs 65-68 in lots of 2,000. With Rs 100 crore revenue and Rs 6.02 crore profit, it's set to list on NSE SME.
Deepak Parekh-backed Nephro Care's IPO GMP soars to 300% on allotment day. Here's how you can check status
Deepak Parekh-backed Nephro Care's IPO GMP soars to 300% on allotment day. Here's how you can check status
Nephro Care IPO opens today: Check issue size, price band, GMP and other details
Invest in the Nephro Care IPO in Kolkata to support healthcare initiatives and gain potential returns through shares.
Nephro Care India IPO: Deepak Parekh-backed company to raise around Rs 40 crore via public issue on NSE Emerge
Deepak Parekh-backed multi-speciality healthcare provider Nephro Care India Limited (NCIL) is likely to raise around Rs 40 crore through the initial public offering (IPO) to fund its expansion plans.
- Go To Page 1
Nephro Care India files DRHP to raise funds via IPO
According to the draft papers, the company’s initial public offering comprises a fresh issuance of 45,84,000 equity shares, each with a face value of Rs 10.
Investcorp closes Rs 323-crore funding round in NephroPlus
The latest transaction will see Sea-Link Capital Partners, the investment firm founded by former KKR senior executive Heramb Hajarnavis, score an exit from its three year-old investment.
How Kamal D Shah’s medical problem inspired NephroPlus, a pan-India kidney care centre
Entrepreneurs are wont to fate as the trigger for their start-ups, but here it was sheer providence that Shah ended up as one of the co-founders of NephroPlus.
Five Indian start-ups made in economic slowdown & lessons they offer
ET is profiling five start-ups that have begun their lives during the ongoing tough times and shares lessons these intrepid companies have to offer.
Five Indian start-ups made in economic slowdown & lessons they offer
ET is profiling five start-ups that have begun their lives during the ongoing tough times and shares lessons these intrepid companies have to offer.
NephroPlus: A startup betting big on walk-in dialysis care
With a global recession underway, the timing for launching a startup might have seemed inopportune, but Vikram Vuppala and his fellow founders had a plan.
NephroPlus: A startup betting big on walk-in dialysis care
With a global recession underway, the timing for launching a startup might have seemed inopportune, but Vikram Vuppala and his fellow founders had a plan.
Load More
